372 documents

Read All
00:14 , May 15, 2012 |  BC Extra  |  Company News

F-star names Haurum CEO, Dancer COO

Antibody company F-star Biotechnologische Forschungs und Entwicklungs GmbH (Vienna, Austria) hired John Haurum as CEO. Haurum is the former VP of research at ImClone Systems Inc. , which Eli Lilly and Co. (NYSE:LLY) acquired 2008....
Read More
07:00 , May 14, 2012 |  BC Week In Review  |  Company News

F-star management update

F-star Biotechnologische Forschungs und Entwicklungs GmbH , Vienna, Austria   Business: Antibodies   Hired: Jane Dancer as COO, formerly VP of business development at Cellzome Ltd.; Sharon Grimster as VP of development, formerly a VP...
Read More
07:00 , Apr 30, 2012 |  BC Week In Review  |  Clinical News

Oforta fludarabine regulatory update

FDA Commissioner Margaret Hamburg revoked accelerated approval of Oforta fludarabine from Sanofi as a second-line therapy to treat B cell chronic lymphocytic leukemia. According to the agency, Sanofi asked FDA to withdraw approval of Oforta,...
Read More
01:04 , Apr 26, 2012 |  BC Extra  |  Company News

FDA pulls Oforta approval

FDA Commissioner Margaret Hamburg revoked accelerated approval of Oforta fludarabine from Sanofi (Euronext:SAN; NYSE:SNY) as a second-line therapy to treat B cell chronic lymphocytic leukemia. According to the agency, Sanofi asked FDA to withdraw approval...
Read More
07:00 , Apr 9, 2012 |  BC Week In Review  |  Company News

Summit management update

Summit Corp. plc (LSE:SUMM), Abingdon, U.K.   Business: Musculoskeletal, Endocrine/Metabolic, Infectious   Hired: Glyn Edwards as CEO and a director, formerly CEO of Antisoma plc  ...
Read More
00:35 , Nov 24, 2011 |  BC Extra  |  Politics & Policy

BIA's Gaymond departing as CEO

The U.K. BioIndustry Association said CEO Nigel Gaymond left to pursue other opportunities. Glyn Edwards will become interim CEO. Edwards was CEO of cancer company Antisoma plc (LSE:ASM)....
Read More
07:00 , Jul 18, 2011 |  BC Week In Review  |  Company News

Clavis management update

Clavis Pharma ASA (OSE:CLAVIS), Oslo, Norway   Business: Drug delivery, Cancer, Infectious   Hired: Nicholas Adams as CBO, formerly VP of business development at Antisoma plc ; he replaces Jan Alfheim, who is departing to...
Read More
07:00 , Jun 20, 2011 |  BC Week In Review  |  Company News

e-Therapeutics management update

e-Therapeutics Ltd. (LSE:ETX), Newcastle, U.K.   Business: Infectious, Cancer   Hired: Daniel Elger as CFO and a director, formerly VP of marketing and communications at Antisoma plc   Departed: J.M. Cordiner as finance director  ...
Read More
07:00 , May 30, 2011 |  BC Week In Review  |  Company News

Genkyotex management update

GenKyoTex S.A. , Geneva, Switzerland   Business: Pulmonary, Renal, Cardiovascular   Hired: Ursula Ney as CEO and executive director, formerly COO at Antisoma plc  ...
Read More
07:00 , May 30, 2011 |  BioCentury  |  Finance

Europe's Iceberg 2011: Unlocking hidden value

The European biotech industry is now about a generation old - long enough for investors and managements to benefit from the experiences of several business cycles. While it is easy to complain about the flaws...
Read More